Sunshine Biopharma Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Sunshine Biopharma Inc. reported Cash And Cash Equivalents At Carrying Value of $21.83 million for the year ending 2022.

  • Sunshine Biopharma Inc. showed an increase of +967.2% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Sunshine Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on April 4, 2023.
  • XBRL data for this metric is available from 2010 to 2022 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2011: $118.1 thousand | Q2 2011: $101.2 thousand | Q3 2011: $178.5 thousand | Q1 2012: $38.4 thousand | Q2 2012: $63.2 thousand | Q3 2012: $255.4 thousand | Q1 2013: $255.9 thousand | Q2 2013: $156.6 thousand | Q3 2013: $71.0 thousand | Q1 2014: $70.5 thousand | Q2 2014: $38.4 thousand | Q3 2014: $173.9 thousand | Q1 2015: $148.7 thousand | Q2 2015: $157.2 thousand | Q3 2015: $125.2 thousand | Q1 2016: $123.3 thousand | Q2 2016: $73.9 thousand | Q3 2016: $21.8 thousand | Q1 2017: $17.1 thousand | Q2 2017: $128.8 thousand | Q3 2017: $188.1 thousand | Q1 2018: $104.8 thousand | Q2 2018: $36.4 thousand | Q3 2018: $46.4 thousand | Q1 2019: $95.1 thousand | Q2 2019: $37.3 thousand | Q3 2019: $82.0 thousand | Q1 2020: $10.8 thousand | Q2 2020: $85.6 thousand | Q3 2020: $488.7 thousand | Q1 2021: $1.80 million | Q2 2021: $1.74 million | Q3 2021: $2.39 million | Q1 2022: $13.18 million | Q2 2022: $41.73 million | Q3 2022: $40.56 million | Q4 2022: $21.83 million | Q1 2023: $19.29 million | Q2 2023: $19.73 million.
  • Over the full 13 years of available data (2010 to 2022), Sunshine Biopharma Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 13,340.7%.
  • Historical annual values: Fiscal year 2022: $21.83 million | Fiscal year 2021: $2.05 million | Fiscal year 2020: $989.9 thousand | Fiscal year 2019: $40.5 thousand | Fiscal year 2018: $110.5 thousand | Fiscal year 2017: $107.5 thousand | Fiscal year 2016: $57.5 thousand | Fiscal year 2015: $50.8 thousand | Fiscal year 2014: $143.4 thousand | Fiscal year 2013: $31.2 thousand | Fiscal year 2012: $132.6 thousand | Fiscal year 2011: $60.7 thousand | Fiscal year 2010: $162.4 thousand.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: